DK2445909T3 - Derivater af 6,7-dihydro-5h-imidazo [1,2-a] imidazol-3-carboxylsyre amider - Google Patents

Derivater af 6,7-dihydro-5h-imidazo [1,2-a] imidazol-3-carboxylsyre amider

Info

Publication number: DK2445909T3
Authority: DK; Denmark
Prior art keywords: imidazo; dihydro; imidazole; derivatives; carboxylic acid
Prior art date: 2009-06-02

Application number

DK10720512.2T

Other languages

English (en)

Inventor

Rene Marc Lemieux

Steven Richard Brunette

Joshua Courtney Horan

Jennifer A Kowalski

Michael David Lawlor

Bryan Mckibben

Craig Andrew Miller

Antonio J M Barbosa

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-06-02

Filing date

2010-05-26

Publication date

2014-02-10

2010-05-26 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2014-02-10 Application granted granted Critical

2014-02-10 Publication of DK2445909T3 publication Critical patent/DK2445909T3/da

Links

SNSPZBPBBIVKMB-UHFFFAOYSA-N 3,7-dihydro-2h-imidazo[1,2-a]imidazole-5-carboxamide Chemical class N1CCN2C(C(=O)N)=CN=C21 SNSPZBPBBIVKMB-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Immunology (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Transplantation (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Neurology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK10720512.2T 2009-06-02 2010-05-26 Derivater af 6,7-dihydro-5h-imidazo [1,2-a] imidazol-3-carboxylsyre amider DK2445909T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US18309809P	2009-06-02	2009-06-02
PCT/US2010/036094 WO2010141273A1 (en)	2009-06-02	2010-05-26	DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES

Publications (1)

Publication Number	Publication Date
DK2445909T3 true DK2445909T3 (da)	2014-02-10

Family

ID=42346128

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK10720512.2T DK2445909T3 (da)	2009-06-02	2010-05-26	Derivater af 6,7-dihydro-5h-imidazo [1,2-a] imidazol-3-carboxylsyre amider

Country Status (19)

Country	Link
US (1)	US8575360B2 (da)
EP (1)	EP2445909B1 (da)
JP (1)	JP5384732B2 (da)
KR (1)	KR20120024699A (da)
CN (1)	CN102448960A (da)
AR (1)	AR076942A1 (da)
AU (1)	AU2010256994A1 (da)
BR (1)	BRPI1012581A2 (da)
CA (1)	CA2764296A1 (da)
CL (1)	CL2011003076A1 (da)
DK (1)	DK2445909T3 (da)
EA (1)	EA019990B1 (da)
ES (1)	ES2446352T3 (da)
IL (1)	IL215521A0 (da)
MX (1)	MX2011012717A (da)
NZ (1)	NZ595622A (da)
PL (1)	PL2445909T3 (da)
TW (1)	TWI443099B (da)
WO (1)	WO2010141273A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RS53602B1 (sr) *	2007-11-29	2015-02-27	Boehringer Ingelheim International Gmbh	DERIVATI AMIDA 6,7-DIHIDRO-5H-IMIDAZO[1,2-α]IMIDAZOL-3-KARBOKSILNE KISELINE
US8481750B2 (en)	2009-06-02	2013-07-09	Boehringer Ingelheim International Gmbh	Derivatives of 6,7-dihydro-5H-imidazo[1,2-α]imidazole-3-carboxylic acid amides
WO2018166855A1 (en)	2017-03-16	2018-09-20	Basf Se	Heterobicyclic substituted dihydroisoxazoles
WO2018234488A1 (en)	2017-06-23	2018-12-27	Basf Se	Substituted cyclopropyl derivatives

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2015493A1 (da)	1968-08-12	1970-04-30	Sumitomo Chemical Co
DK123717B (da)	1968-11-25	1972-07-24	Sumitomo Chemical Co	3-(3',5'-Dihalogenphenyl)-imidazolidin-2,4-dionderivater med mirobicid virkning.
JPS5136332B1 (da)	1970-12-09	1976-10-07
EP0091596B1 (de)	1982-04-08	1991-09-11	Shell Internationale Researchmaatschappij B.V.	Neue Hydantoine, ihre Herstellung und Verwendung
JPS63270665A (ja)	1987-04-30	1988-11-08	Wakamoto Pharmaceut Co Ltd	イミダゾ−ル誘導体
JPS63270667A (ja)	1987-04-30	1988-11-08	Wakamoto Pharmaceut Co Ltd	１−ベンジルイミダゾ−ル誘導体
IE940525L (en)	1988-05-25	1989-11-25	Warner Lambert Co	Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
US5306822A (en)	1988-05-25	1994-04-26	Warner-Lambert Company	Arylmethylenyl derivatives of oxazolidinone
US5208250A (en)	1988-05-25	1993-05-04	Warner-Lambert Company	Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents
US4977270A (en)	1988-12-01	1990-12-11	Ici Americas Inc.	Substituted 2,4-dioxodiazolidines and -thiadiazolidines and their use as herbicides
US4911748A (en)	1988-12-22	1990-03-27	Ici Americas Inc.	Herbicidal 5-substituted-3-phenyl-imidazolidine-2,4-diones
JPH04273877A (ja)	1991-02-28	1992-09-30	Sumitomo Pharmaceut Co Ltd	新規なイミダゾール誘導体
EP0545478A1 (en)	1991-12-03	1993-06-09	MERCK SHARP & DOHME LTD.	Heterocyclic compounds as tachykinin antagonists
JPH05188631A (ja)	1992-01-10	1993-07-30	Mita Ind Co Ltd	電子写真感光体
TW521073B (en)	1994-01-05	2003-02-21	Hoechst Marion Roussel Inc	New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
US20040006011A1 (en)	1996-07-12	2004-01-08	Gour Barbara J.	Peptidomimetic modulators of cell adhesion
NZ507848A (en)	1996-10-28	2005-01-28	Univ Washington	Method of increasing the mutation rate of a virus in a non-human by administering an RNA nucleoside analogue to a virally infected cell
US6355664B1 (en)	1997-03-03	2002-03-12	Boehringer Ingelheim Pharmaceuticals, Inc.	Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
PT966447E (pt)	1997-03-03	2003-07-31	Boehringer Ingelheim Pharma	Moleculas pequenas uteis no tratamento de doencas inflamatorias
ES2306482T3 (es)	1997-08-28	2008-11-01	Novartis Ag	Antagonistas de antigeno-1 funcion con funcion de linfocito.
CA2325986A1 (en)	1998-03-27	1999-10-07	Genentech, Inc.	Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
RU2001132141A (ru) *	1999-04-28	2004-03-20	БАСФ Акциенгезельшафт (DE)	Антагонисты интегриновых рецепторов
US6492408B1 (en)	1999-07-21	2002-12-10	Boehringer Ingelheim Pharmaceuticals, Inc.	Small molecules useful in the treatment of inflammatory disease
US6353013B1 (en)	1999-07-21	2002-03-05	Boehringer Ingelheim Pharmaceuticals, Inc.	Small molecules useful in the treatment of inflammatory disease
US6365615B1 (en)	1999-07-21	2002-04-02	Boehringer Ingelheim Pharmaceuticals, Inc.	Small molecules useful in the treatment of inflammatory disease
MXPA02000625A (es)	1999-07-21	2002-07-02	Boehringer Ingelheim Pharma	Pequenas moleculas utiles en el tratamiento de enfermedades inflamatorias.
WO2001007048A1 (en)	1999-07-21	2001-02-01	Boehringer Ingelheim Pharmaceuticals, Inc.	Small molecules useful in the treatment of inflammatory disease
CN1185232C (zh)	1999-10-20	2005-01-19	田边制药株式会社	αLβ2介导细胞粘连抑制剂
WO2002050080A1 (en)	2000-12-19	2002-06-27	Boehringer Ingelheim Pharmaceuticals, Inc.	Small molecules useful in the treatment of inflammatory disease
DE60303441T2 (de) *	2002-02-08	2006-09-21	Merck & Co., Inc.	N-biphenylmethylaminocycloalkancarboxamid-derivative
US20030232817A1 (en)	2002-05-29	2003-12-18	Boehringer Ingelheim Pharmaceuticals, Inc.	Small molecules useful for the treatment of inflammatory disease
IL166426A0 (en) *	2002-08-29	2006-01-15	Merck & Co Inc	N-biarylmethyl aminocycloalkanecarboxamide derivatives
US6852748B1 (en)	2002-10-30	2005-02-08	Boehringer Ingelheim Pharmaceuticals, Inc.	Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
US6844360B2 (en) *	2002-10-30	2005-01-18	Boehringer Ingelheim Pharmaceuticals, Inc.	Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
CA2573398A1 (en)	2004-07-27	2006-02-09	Boehringer Ingelheim International Gmbh	Synthesis of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides
WO2006107923A1 (en)	2005-04-05	2006-10-12	Boehringer Ingelheim International Gmbh	Substituted benzylimidazoles useful for the treatment of inflammatory diseases
CA2603214A1 (en)	2005-04-06	2006-10-12	Steven Richard Brunette	Derivatives of[6,7-dihydro-5himidazo[1,2-alpha]imidazole-3-sulfonyl]-azetedine-carboxylic acids, esters and amides and use thereof as anti-inflammatory agents
JP2008540648A (ja)	2005-05-19	2008-11-20	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	６，７−ジヒドロ−５Ｈ−イミダゾ［１，２−ａ］イミダゾール−３−スルホン酸
RS53602B1 (sr)	2007-11-29	2015-02-27	Boehringer Ingelheim International Gmbh	DERIVATI AMIDA 6,7-DIHIDRO-5H-IMIDAZO[1,2-α]IMIDAZOL-3-KARBOKSILNE KISELINE
US8908100B2 (en)	2007-12-28	2014-12-09	Entropic Communications, Inc.	Arrangement and approach for motion-based image data processing
US8481750B2 (en)	2009-06-02	2013-07-09	Boehringer Ingelheim International Gmbh	Derivatives of 6,7-dihydro-5H-imidazo[1,2-α]imidazole-3-carboxylic acid amides

2010
- 2010-05-26 BR BRPI1012581A patent/BRPI1012581A2/pt not_active IP Right Cessation
- 2010-05-26 PL PL10720512T patent/PL2445909T3/pl unknown
- 2010-05-26 NZ NZ595622A patent/NZ595622A/en not_active IP Right Cessation
- 2010-05-26 JP JP2012513982A patent/JP5384732B2/ja active Active
- 2010-05-26 EP EP10720512.2A patent/EP2445909B1/en active Active
- 2010-05-26 MX MX2011012717A patent/MX2011012717A/es active IP Right Grant
- 2010-05-26 US US13/375,767 patent/US8575360B2/en active Active
- 2010-05-26 ES ES10720512.2T patent/ES2446352T3/es active Active
- 2010-05-26 EA EA201101702A patent/EA019990B1/ru not_active IP Right Cessation
- 2010-05-26 WO PCT/US2010/036094 patent/WO2010141273A1/en not_active Ceased
- 2010-05-26 CA CA2764296A patent/CA2764296A1/en not_active Abandoned
- 2010-05-26 AU AU2010256994A patent/AU2010256994A1/en not_active Abandoned
- 2010-05-26 KR KR1020117028828A patent/KR20120024699A/ko not_active Withdrawn
- 2010-05-26 DK DK10720512.2T patent/DK2445909T3/da active
- 2010-05-26 CN CN2010800231326A patent/CN102448960A/zh active Pending
- 2010-06-01 TW TW099117646A patent/TWI443099B/zh not_active IP Right Cessation
- 2010-06-01 AR ARP100101925A patent/AR076942A1/es unknown
2011
- 2011-10-04 IL IL215521A patent/IL215521A0/en unknown
- 2011-12-02 CL CL2011003076A patent/CL2011003076A1/es unknown

Also Published As

Publication number	Publication date
ES2446352T3 (es)	2014-03-07
AR076942A1 (es)	2011-07-20
JP5384732B2 (ja)	2014-01-08
EA019990B1 (ru)	2014-07-30
CN102448960A (zh)	2012-05-09
NZ595622A (en)	2014-02-28
EA201101702A1 (ru)	2012-08-30
KR20120024699A (ko)	2012-03-14
CA2764296A1 (en)	2010-12-09
US8575360B2 (en)	2013-11-05
EP2445909A1 (en)	2012-05-02
WO2010141273A1 (en)	2010-12-09
JP2012528859A (ja)	2012-11-15
TWI443099B (zh)	2014-07-01
EP2445909B1 (en)	2013-11-13
MX2011012717A (es)	2011-12-14
IL215521A0 (en)	2011-12-29
BRPI1012581A2 (pt)	2016-03-29
PL2445909T3 (pl)	2014-04-30
AU2010256994A1 (en)	2011-11-03
US20120252817A1 (en)	2012-10-04
CL2011003076A1 (es)	2012-08-17
TW201109332A (en)	2011-03-16

Publication	Publication Date	Title
CY2021001I2 (el)	2023-01-05	Παραγωγα ετεροκυκλικου αμιδιου χρησιμα ως μικροβιοκτονα
ZA201203615B (en)	2015-03-25	Derivatives of 1-amino-2-cyclobutylethylboronic acid
DK2192109T3 (da)	2013-12-16	BICYKLISKE y-AMINOSYREDERIVATER
BRPI1008749A2 (pt)	2015-08-25	Derivados de benzodiazepina
EP2471786A4 (en)	2013-03-27	aminopyrazole derivative
BRPI0819831A2 (pt)	2019-09-24	derivados de amidas de áciodo 6,7-diidro-5h-imidazo[1,2-a]imidazol-3-carboxílico
EP2511268A4 (en)	2013-04-17	oxazine
BRPI0914301A2 (pt)	2015-10-13	derivados de pirimidin-4-ona substituída
BRPI0913833A2 (pt)	2015-10-20	uso de corantes ácidos
CU24155B1 (es)	2016-03-31	DERIVADOS DE 1-(5,6-DIHIDROIMIDAZO(1,2-a)PIRAZIN-7(8H)-IL )ETANONA
BRPI0810660A2 (pt)	2014-10-07	Derivados do ácido lipóico
IL217001A0 (en)	2012-02-29	Preparation of substituted 2-fluoroacrylic acid derivatives
DK2513063T3 (da)	2014-01-06	Fremgangsmåde til fremstilling af 1-alkyl-/1-aryl-5-pyrazolcarboxylsyrederivater
EP2462133A4 (en)	2013-01-16	5-fluoro-2-oxopyrimidine-1 (2H) -carboxylate DERIVATIVES
BR112012005503A2 (pt)	2016-04-19	derivados de isoxazolidina
EP2231687A4 (en)	2012-11-14	NEW DERIVATIVES OF ACYL-CYANPYRROLIDINES
DK2421869T3 (da)	2015-06-08	Rifamycinderivat
DK2462098T3 (da)	2013-11-25	Fremgangsmåde til fremstillingen af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre
CU23884B1 (es)	2013-04-19	Derivados de dibenzotiazepina
EP2632255A4 (en)	2014-07-23	Diazeniumdiolate heterocyclic derivatives
GB0604899D0 (en)	2006-04-19	Derivatives of 18-glycyrrhetinic acid
EP2560955A4 (en)	2013-09-11	NEW BENZAMIDE DERIVATIVES
EP2623503A4 (en)	2014-03-05	CHROME DERIVATIVES
IL206524A0 (en)	2010-12-30	4-dimethylminobutyric acid derivatives
DK2493860T3 (da)	2014-04-07	Fremgangsmåde til fremstilling af 4-sulfinylpyrazolderivater